The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.
about
The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@en
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@nl
type
label
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@en
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@nl
prefLabel
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@en
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@nl
P2093
P2860
P1476
The Hedgehog inhibitor cyclopa ...... patients with advanced cancer.
@en
P2093
Akifumi Kiyota
Hideya Onishi
Hiroto Tanaka
Masayo Umebayashi
Mitsuo Katano
Norihiro Koya
Takashi Morisaki
P2860
P2888
P304
P356
10.1007/S00262-013-1419-5
P577
2013-04-17T00:00:00Z